NCT01460264Enrolling by invitation
An Open Prospective Longitudinal Pulmonary-cardiovascular Cohort Study
BIG3 - An Open Prospective Longitudinal Pulmonary-cardiovascular Cohort Study
Source: ClinicalTrials.gov · Last updated 29 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This is an observational study aiming to identify and validate biomarkers (including imaging and clinical descriptors) for chronic obstructive pulmonary disease (COPD), cardiovascular disease (CVD) and lung cancer.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 10000 (estimated)
- First submitted
- 25 Oct 2011
- Start date
- 16 Oct 2013
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Region Skane
- Diseases
- COPD, Lung cancer
- NCT number
- NCT01460264
What you commit to
- Study type: Observational
- Planned participants: 10000
- From 16 Oct 2013 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- 45-75 years
Age in the registry: 45 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Skåne University Hospital Coordinator of this site? Confirm its status | Lund | Sweden | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.